Halozyme Therapeutics Inc (NASDAQ:HALO)

42.18
BATS BZX Real-Time Price
As of 3:10pm ET
 +0.93 / +2.25%
Today’s Change
25.17
Today|||52-Week Range
56.40
-1.24%
Year-to-Date

Today’s Trading

Previous close41.25
Today’s open41.18
Day’s range41.15 - 42.18
Volume19,282
Average volume (3 months)838,189
Market cap$6.0B
Data as of 3:10pm ET, 09/16/2021

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+81.32%
Earnings growth (next 5 years)+43.00%
Revenue growth (last year)+36.53%
P/E ratio26.7
Price/Sales22.58
Price/Book37.73

Competitors

 Today’s
change
Today’s
% change
BPMCBlueprint Medicines ...-0.52-0.50%
TWSTTwist Bioscience Cor...+0.28+0.25%
----
FATEFate Therapeutics In...+0.44+0.66%
Data as of 3:10pm ET, 09/16/2021

Financials

Next reporting dateNovember 8, 2021
EPS forecast (this quarter)$0.43
Annual revenue (last year)$267.6M
Annual profit (last year)$129.1M
Net profit margin48.24%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
--, --

Forecasts